Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR

BACKGROUND: Creatinine-based estimated glomerular filtration rate (eGFR(CRE)) may overestimate kidney function in patients with cancer. Cystatin C-based eGFR (eGFR(CYS)) is an alternative marker of kidney function. We investigated whether patients with an eGFR discrepancy, defined as eGFR(CYS) >3...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Paul E., Wang, Qiyu, Strohbehn, Ian, Moreno, Daiana, Harden, Destiny, Ouyang, Tianqi, Katz-Agranov, Nurit, Seethapathy, Harish, Reynolds, Kerry L., Gupta, Shruti, Leaf, David E., Sise, Meghan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882433/
https://www.ncbi.nlm.nih.gov/pubmed/36711583
http://dx.doi.org/10.1101/2023.01.18.23284656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882433/
https://www.ncbi.nlm.nih.gov/pubmed/36711583
http://dx.doi.org/10.1101/2023.01.18.23284656

Ejemplares similares